Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:7NS0
Stock Latest News
Ratings
Palisade Bio Buy Rating Reiterated as New Crohn’s Data Impress; 12-Month Price Target Maintained at $7
30m ago
PALI
Premium
The Fly
Palisade Bio initiated with an Outperform at Raymond James
5d ago
PALI
Premium
The Fly
Palisade Bio to present clinical, translational data for PALI-2108 at UEG Week
15d ago
PALI
Premium
The Fly
Palisade Bio expands Phase 2b Ascentra-UC with Health Canada CTA clearance
20d ago
PALI
Premium
The Fly
Palisade Bio receives FDA clearance of IND for PALI-2108
21d ago
PALI
Premium
Ratings
Kapoor Reiterates Buy on Palisade Bio, Maintains $7 Price Target as PALI-2108 Advances into Phase 2 IBD Trials
2M ago
PALI
Premium
The Fly
Palisade Bio reports Q2 EPS (22c), consensus (5c)
2M ago
PALI
Premium
The Fly
Midday Fly By: Alphabet boosts spending, IBM reports downbeat Q2
3M ago
T
AAL
Premium
The Fly
Palisade Bio initiated with an Outperform at Oppenheimer
3M ago
PALI
Premium
The Fly
Palisade Bio management to meet with Piper Sandler
3M ago
PALI
Premium
The Fly
Midday Fly By: SpaceX to join Nasdaq-100, Comcast to split into two companies
4M ago
VZ
CRM
Premium
The Fly
Palisade Bio receives FDA clearance to start ulcerative colitis study
4M ago
PALI
Premium
Company Announcements
Palisade Bio Shareholders Approve Charter Amendments, Governance Matters
4M ago
8K
PALI
Premium
The Fly
Palisade Bio files $300M mixed securities shelf
5M ago
PALI
Premium
The Fly
Palisade Bio initiated with an Outperform at Wolfe Research
6M ago
PALI
Premium
Company Announcements
Palisade Bio partners with Iterative Health to advance PALI-2108
6M ago
8K
PALI
Premium
The Fly
Palisade Bio reaction to PALI-2108 data ‘looks misaligned’, says Clear Street
7M ago
PALI
Premium
The Fly
Palisade Bio announces topline data from PALI-2108 trial
7M ago
PALI
Premium
The Fly
Palisade Bio initiated with a Buy at H.C. Wainwright
7M ago
PALI
Premium
The Fly
Palisade Bio initiated with a Buy at Stifel
8M ago
PALI
Premium
The Fly
Palisade Bio announces presentation of new data for PALI-2108
8M ago
PALI
Premium
The Fly
Palisade Bio appoints Verstockt to its Clinical Advisory Board
8M ago
PALI
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
